Intrauterine Devices Market Size, Share, Growth Analysis, By Type(Nonhormonal, copper-containing IUDs and hormonal, progestogen-releasing IUDs), By Age(15–24 years, 25–34 years, 35–44 years, and above 44 years), By End-user(Hospitals, community health centers, clinics, and others), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35A2678 | Region: Global | Published Date: February, 2024
Pages: 157 |Tables: 92 |Figures: 76

Intrauterine Devices Market Insights

Intrauterine Devices Market size was valued at USD 3.0 billion in 2021 and is poised to grow from USD 3.12 billion in 2022 to USD 4.20 billion by 2030, at a CAGR of 3.8% during the forecast period (2023-2030).

Several factors drive the growth of the intrauterine devices market. These include an increase in the number of unplanned and unintended pregnancies, a rise in unsafe abortions, and growing awareness regarding the use of these devices.

The demand for intrauterine devices is also on the rise, supported by initiatives from governments and key players in the research and development sector to develop advanced devices. Additionally, the increase in unintended pregnancies and supportive government initiatives contribute to market growth. The trend of planned delayed pregnancy in the U.S. further fuels this growth, with the U.S. government adopting strategies to promote access to sexual and reproductive health services and products.

However, there are challenges hindering the growth of the intrauterine device market. These include a lack of awareness about the use of IUDs and potential side effects such as bleeding, pain, and discomfort. Many women have their IUDs removed before the recommended replacement time due to these side effects. Other common side effects after IUD placement include cramps, irregular periods, spotting between periods, and heavier periods with stronger cramping. These factors impede market growth.

Nevertheless, the rising disposable income and demand for a healthy lifestyle in emerging economies present opportunities for key market players. Favorable regulatory scenarios, technological advancements, and government initiatives also contribute to the market's potential for growth. Ongoing advancements and innovations aimed at enhancing the patient experience are expected to further propel market growth.

US Intrauterine Devices Market is poised to grow at a sustainable CAGR for the next forecast year.

Market Snapshot - 2024-2031

Global Market Size

USD 3.0 billion

Largest Segment

25-34 years

Fastest Growth

Growth Rate

3.8% CAGR

Global Intrauterine Devices Market ($ Bn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Intrauterine Devices Market Segmental Analysis

The global intrauterine devices market is segmented on the basis of type, age group, end-user, and region. By type, the market is classified into nonhormonal, copper-containing IUDs hormonal, and progestogen-releasing IUDs. By age group, it is categorized into 15–24 years, 25–34 years, 35–44 years, and above 44 years. By end-user, it is classified into hospitals, community health centers, clinics, and others. By region, it is analyzed across four regions, namely, North America, Latin America, Europe, Asia-Pacific, and MEA.

Intrauterine Devices Market Analysis By Type

Copper-containing IUDs offer a highly effective and reliable contraceptive solution that does not rely on hormones. This segment will dominate the global intrauterine devices market. Moreover, their hormone-free nature makes them suitable for women who prefer non-hormonal birth control options or may have contraindications to hormonal methods.

On the other hand, the fastest-growing segment in the intrauterine devices market is the hormonal IUDs that release progestogen. With increasing awareness about hormonal IUDs and their multiple benefits, this segment is witnessing rapid growth as more women opt for a reliable and hormone-based contraceptive solution that also addresses other menstrual health concerns.

Intrauterine Devices Market Analysis By Age

The age group of 25–34 years represents the largest share of the intrauterine devices market. Intrauterine Devices provide them with a trusted option, allowing them to confidently pursue their goals while maintaining control over their reproductive choices. With their effectiveness, convenience, and long-lasting nature, IUDs have become the preferred choice for many women in this age group.

On the other hand, the age group of 15–24 years represents the fastest-growing segment in the intrauterine devices market . The accessibility, effectiveness, and low-maintenance nature of IUDs make them an attractive option for this age group. The growing recognition of the importance of reproductive health in this age group has fueled the rapid growth of Intrauterine Devices as the go-to contraceptive method.

Global Intrauterine Devices Market By Age

To get detailed analysis on other segments, Request For Free Sample Report

Intrauterine Devices Market Regional Insights

North America represents the largest share of the intrauterine devices market. This region is known for its advanced healthcare infrastructure, high awareness about reproductive health, and widespread availability of contraceptive options. The demand for IUDs in North America is driven by a combination of factors, including a growing trend towards planned delayed pregnancies, increasing focus on women's reproductive rights, and a strong emphasis on family planning. Additionally, the region benefits from favorable government policies and initiatives that promote access to sexual and reproductive health services. With a well-established market and a population that values effective and long-term contraceptive solutions, North America continues to drive the growth of the intrauterine devices market .

On the other hand, the Asia Pacific region represents the fastest-growing segment in the intrauterine devices market . This region is witnessing a significant surge in awareness and demand for modern contraceptive methods, including IUDs. Factors contributing to the growth of IUDs in Asia Pacific include a large population, increasing urbanization, rising disposable incomes, and a growing focus on women's health and empowerment. The region's dynamic economies, such as China and India, are experiencing rapid urban development and improvements in healthcare infrastructure, enabling better access to reproductive healthcare services. Additionally, initiatives by governments and non-governmental organizations to promote family planning and contraceptive use have further fueled the adoption of IUDs in the region. With a rising population of women of reproductive age and a growing recognition of the importance of family planning, Asia Pacific is emerging as a thriving market for Intrauterine Devices.

Global Intrauterine Devices Market By Geography
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Intrauterine Devices Market Dynamics

Intrauterine Devices Market Drivers

Increasing Awareness and Adoption of Contraception

  • The growing awareness about the importance of family planning and the need for effective contraception methods has been a major driver for the intrauterine devices market . As individuals and healthcare providers recognize the benefits of long-term birth control options, the demand for IUDs has increased.
  • Unintended pregnancies remain a global health concern. Intrauterine devices offer a highly effective and reversible form of contraception, which is driving their adoption. The desire to prevent unintended pregnancies and the associated social and economic implications are key drivers for the market.

Intrauterine Devices Market Restraints

Stringent Regulatory Requirements

  • Intrauterine devices are medical devices that are subject to stringent regulatory oversight to ensure their safety and effectiveness. Meeting regulatory requirements, obtaining necessary approvals, and maintaining compliance can be challenging for manufacturers. These regulations can act as a barrier to entry for new market players and hinder market growth.
  • While intrauterine devices are generally considered safe and effective, there can be associated risks and side effects. Perceived risks and concerns related to insertion complications, infections, perforation, and expulsion can affect patient acceptance and limit market growth. Addressing these safety concerns through proper education and improved device design is crucial.

Request Free Customization of this report to help us to meet your business objectives.

Intrauterine Devices Market Competitive Landscape

Given the importance of accessibility and affordability in the contraceptive market, some players adopt competitive pricing strategies. They may offer discounted or subsidized IUDs to make them more accessible to a broader population, especially in developing countries. Effective marketing and awareness campaigns are essential to educate healthcare providers and potential users about the benefits of IUDs. Companies invest in promoting their products through digital and traditional marketing channels, attending medical conferences, and conducting educational workshops.

Intrauterine Devices Market Top Player’s Company Profiles

  • Actavis (Ireland)
  • Bayer (Germany)
  • Teva Pharmaceuticals (Israel)
  • Allergan (Ireland)
  • Eurogine (Spain)
  • OCON Medical (Israel)
  • Pregna (India)
  • HLL Lifecare (India)
  • HRA Pharma (France)
  • ANI Pharmaceuticals (United States)
  • Besins HealthCare (Belgium)
  • SMB (India)
  • Medicines360 (United States)
  • Medisafe Distribution (France)
  • MonaLisa N.V. (Belgium)
  • Merck & Co., Inc. (United States)
  • Pfizer Inc. (United States)
  • Trimedic Supply Network Ltd. (United Kingdom)
  • Melbea AG (Switzerland)
  • Medisafe UK Ltd. (United Kingdom)

Intrauterine Devices Market Recent Developments

  • In June 2021, Sebela Pharmaceuticals Inc. partnered with PRA Health Sciences to conduct a phase III clinical trial for LevoCept, a long-acting reversible intrauterine system. The trial aims to evaluate the contraceptive efficacy, safety, and tolerability of LevoCept and is expected to be completed by June 2027.

Intrauterine Devices Key Market Trends

  • The demand for Intrauterine Devices (IUDs) is being positively influenced by the increasing prevalence of unplanned and unwanted pregnancies worldwide. Furthermore, hormonal IUDs are gaining recognition for their potential to alleviate severe cramps, heavy periods, and anemia in individuals. Efforts undertaken by health agencies and non-profit organizations in various countries to raise awareness about family planning, the benefits of birth control methods, and the health risks associated with unintended pregnancies are also contributing to the market's growth. Additionally, IUDs are becoming increasingly popular among nulliparous women and adolescents who have never given birth, as these devices have a significantly lower risk of ectopic pregnancy and adverse birth outcomes, such as breast and reproductive cancers.

Intrauterine Devices Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Deployment mode team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

According to our analyses, The global intrauterine devices market has witnessed significant growth and is poised for further expansion. Factors such as increasing awareness about contraception, rising prevalence of unintended pregnancies, and the need for long-term birth control options have contributed to the market's growth. The market is expected to further expand as advanced product variants, including postpartum, slimmer, and reusable IUDs with reduced side effects, are developed, offering attractive growth opportunities for investors in the industry. Several players are engaging in women's health advocacy initiatives, supporting research, and partnering with organizations working to advance women's reproductive health. These efforts can enhance their reputation and foster a positive brand image.

Report Metric Details
Market size value in 2023 USD 3.0 billion
Market size value in 2031 USD 4.20 billion
Growth Rate 3.8%
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Type
    • Nonhormonal, copper-containing IUDs and hormonal, progestogen-releasing IUDs
  • Age
    • 15–24 years, 25–34 years, 35–44 years, and above 44 years
  • End-user
    • Hospitals, community health centers, clinics, and others
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Actavis (Ireland)
  • Bayer (Germany)
  • Teva Pharmaceuticals (Israel)
  • Allergan (Ireland)
  • Eurogine (Spain)
  • OCON Medical (Israel)
  • Pregna (India)
  • HLL Lifecare (India)
  • HRA Pharma (France)
  • ANI Pharmaceuticals (United States)
  • Besins HealthCare (Belgium)
  • SMB (India)
  • Medicines360 (United States)
  • Medisafe Distribution (France)
  • MonaLisa N.V. (Belgium)
  • Merck & Co., Inc. (United States)
  • Pfizer Inc. (United States)
  • Trimedic Supply Network Ltd. (United Kingdom)
  • Melbea AG (Switzerland)
  • Medisafe UK Ltd. (United Kingdom)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Intrauterine Devices Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Intrauterine Devices Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Intrauterine Devices Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Intrauterine Devices Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Intrauterine Devices Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Intrauterine Devices Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?
REQUEST FREE CUSTOMIZATION

FAQs

Intrauterine Devices Market size was valued at USD 3.0 billion in 2021 and is poised to grow from USD 3.12 billion in 2022 to USD 4.20 billion by 2030, at a CAGR of 3.8% during the forecast period (2023-2030).

Given the importance of accessibility and affordability in the contraceptive market, some players adopt competitive pricing strategies. They may offer discounted or subsidized IUDs to make them more accessible to a broader population, especially in developing countries. Effective marketing and awareness campaigns are essential to educate healthcare providers and potential users about the benefits of IUDs. Companies invest in promoting their products through digital and traditional marketing channels, attending medical conferences, and conducting educational workshops. 'Actavis (Ireland)', 'Bayer (Germany)', 'Teva Pharmaceuticals (Israel)', 'Allergan (Ireland)', 'Eurogine (Spain)', 'OCON Medical (Israel)', 'Pregna (India)', 'HLL Lifecare (India)', 'HRA Pharma (France)', 'ANI Pharmaceuticals (United States)', 'Besins HealthCare (Belgium)', 'SMB (India)', 'Medicines360 (United States)', 'Medisafe Distribution (France)', 'MonaLisa N.V. (Belgium)', 'Merck & Co., Inc. (United States)', 'Pfizer Inc. (United States)', 'Trimedic Supply Network Ltd. (United Kingdom)', 'Melbea AG (Switzerland)', 'Medisafe UK Ltd. (United Kingdom)'

The growing awareness about the importance of family planning and the need for effective contraception methods has been a major driver for the intrauterine devices market . As individuals and healthcare providers recognize the benefits of long-term birth control options, the demand for IUDs has increased.

The demand for Intrauterine Devices (IUDs) is being positively influenced by the increasing prevalence of unplanned and unwanted pregnancies worldwide. Furthermore, hormonal IUDs are gaining recognition for their potential to alleviate severe cramps, heavy periods, and anemia in individuals. Efforts undertaken by health agencies and non-profit organizations in various countries to raise awareness about family planning, the benefits of birth control methods, and the health risks associated with unintended pregnancies are also contributing to the market's growth. Additionally, IUDs are becoming increasingly popular among nulliparous women and adolescents who have never given birth, as these devices have a significantly lower risk of ectopic pregnancy and adverse birth outcomes, such as breast and reproductive cancers.

North America represents the largest share of the intrauterine devices market. This region is known for its advanced healthcare infrastructure, high awareness about reproductive health, and widespread availability of contraceptive options. The demand for IUDs in North America is driven by a combination of factors, including a growing trend towards planned delayed pregnancies, increasing focus on women's reproductive rights, and a strong emphasis on family planning. Additionally, the region benefits from favorable government policies and initiatives that promote access to sexual and reproductive health services. With a well-established market and a population that values effective and long-term contraceptive solutions, North America continues to drive the growth of the intrauterine devices market .

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Intrauterine Devices Market

Report ID: SQMIG35A2678

sales@skyquestt.com
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE